The Government has announced it will not oppose Opposition proposals in the Dáil to make cannabis available for medicinal purposes.
Minister for Health Simon Harris confirmed he will facilitate a Bill put forward by People Before Profit TD Gino Kenny and allow it to progress to committee stage in the Dáil.
His statement came following a meeting with Mr Kenny and his Dáil colleague, Richard Boyd Barrett.
Mr Harris said he did not agree with all of the contents of the proposed legislation.
"However, on the central objective of the Bill, access to medicinal cannabis products, I accept the deputies' bona fides, share their desire to make progress on this matter and it is clear there is much common ground on this across the Oireachtas.
“Therefore, while there are elements of the Bill I do not and will not support, I don’t wish to divide the Dáil on this issue and will not oppose the Bill at second stage.”
Cannabis research
The Bill has already secured the support of Fianna Fáil, Sinn Féin, Labour, the Social Democrats, the Green Party and the Anti-Austerity Alliance.
Fine Gael had initially said it would oppose the legislation and await the recommendations of a review by the Health Products Regulatory Authority (HPRA).
The Bill, which is to be debated on Thursday, provides for the regulation of cannabis for medicinal use – so that patients can receive a legally protected, secure supply that is safe and effective.
It also proposes the establishment of a cannabis regulatory authority, which would be tasked with regulating the sale, labelling, advertising and marketing of cannabis and related products.
A Cannabis research institute, which would conduct or commission and publish cannabis-related research, has also been proposed.
Mr Harris said he had serious concerns about those measures and would be tabling a number of amendments to the Bill.
The Minister said: “In particular, it includes removing references to cannabis from the Misuse of Drugs Act which has the effect of making it legal for anyone to possess cannabis, including for recreational purposes.
“It also proposes establishing two new agencies but the appropriate agency to oversee any change to the regulatory regime for medicinal cannabis already exists in the form of the HPRA.
“I understand from my meeting with the deputies yesterday that they are cognisant of the unintended consequences that could flow from these aspects of the Bill and are willing to make amendments in this regard.”
Mr Harris said he would not be progressing the Bill until the report from the HPRA was received.
Prescription
Under the Misuse of Drugs Acts 1977 to 2016, cannabis is subject to stringent controls.
A doctor can prescribe cannabis products in limited circumstances, if granted a licence by the Minister for Health.
One cannabis-based medicine, Sativex, is authorised for the treatment of multiple sclerosis in limited circumstances.
Legislation could be amended to allow for its prescription on a wider basis.
Cannabis for medicinal use is permitted in the Netherlands, Croatia, Malta, the Czech Republic, Australia, Canada and a number of US states.
The Bill is also expected to receive the support of three members of the Independent Alliance, including Minister of State at the Department of Health Finian McGrath.